Montag & Associates’s GoodRx Holdings GDRX Stock Holding History

Montag & Associates’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-75	Closed	-$3K	–	870
2021 Q1	$3K	Buy	+75	New	+$3.37K	﹤0.01%	777

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Montag & Associates's GDRX Position: Q2 2021 in Review

Montag & Associates sold out of GoodRx Holdings (GDRX) in Q2 2021, closing a stake of 75 shares — an estimated $3K sold.

Montag & Associates first reported a position in GDRX in Q1 2021 and held it in 1 quarter. The position peaked at $3K in Q1 2021. 199 funds tracked by Wall St. Rank hold GDRX as of Q2 2021.

Montag & Associates reported no remaining GoodRx Holdings position as of Q2 2021 after selling out during the quarter.
Montag & Associates sold 75 GoodRx Holdings shares in Q2 2021, an estimated $3K.
Montag & Associates first reported a position in GoodRx Holdings in Q1 2021 and held it in 1 quarter.
Montag & Associates's GoodRx Holdings position peaked at $3K in Q1 2021.
199 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2021.

Based on Montag & Associates's 13F filing for Q2 2021, filed 3 Aug 2021.